Alector, Inc. - Common Stock (ALEC)
1.1150
-0.0650 (-5.51%)
NASDAQ · Last Trade: Apr 3rd, 11:28 AM EDT

Alector's AL002 fails in Phase 2 Alzheimer's trial, halting extension study; focus shifts to other programs as workforce is cut by 17%.
Via Benzinga · November 26, 2024

Via Benzinga · November 26, 2024

Via Benzinga · November 26, 2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
Via Benzinga · February 27, 2024

Alector shares are trading lower by 14.9% during Wednesday's session. The company announced the pricing of a $75 million public offering.
Via Benzinga · January 17, 2024

Alector's AL002 misses primary endpoint in Alzheimer's trial. BofA downgrades stock, cuts price target, and highlights near-term challenges.
Via Benzinga · December 4, 2024

Via Talk Markets · November 30, 2024

Via Benzinga · November 26, 2024

Via Benzinga · November 26, 2024

Via Benzinga · November 26, 2024

Via Benzinga · June 10, 2024

ALEC stock results show that Alector beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 8, 2024

The FDA has delayed making a decision on Eli Lilly's donanemab, pending an advisory committee meeting.
Via Investor's Business Daily · March 28, 2024

We're starting Wednesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on this morning!
Via InvestorPlace · March 6, 2024

These three companies are developing treatments for brain diseases that have a great deal of potential, making them top neuroscience stocks.
Via InvestorPlace · January 23, 2024

Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announced a partnership with GCT Semiconductor to develop an RF module. Airspan Networks Holdings shares surged 381% to $0.3699 on Wednesday.
Via Benzinga · January 17, 2024

U.S. stocks traded lower, with the Nasdaq Composite falling more than 150 points on Wednesday.
Via Benzinga · January 17, 2024

Via Benzinga · January 16, 2024

Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.
Via Investor's Business Daily · January 5, 2024

U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Friday. Here are some other big stocks recording gains in today’s session.
Via Benzinga · December 15, 2023

Stifel has upgraded Alector Inc (NASDAQ: ALEC), noting that while Alzheimer's is a very high risk, the probability of success for AL002 (TREM2 agonist) is above average, and the stock risk/reward is highly attractive ahead of phase 2 data in expected in Q4 2024.
Via Benzinga · December 14, 2023